|
Mr. Bradbury has been our Chief Executive Officer since March 2007 serving as President since June 2006 and as Chief Operating Officer since June 2003. He has served as a director since June 2006. He previously served as Executive Vice President from June 2000 until his promotion in June 2003. He joined Amylin in 1994 and has held officer-level positions in Corporate Development and Marketing during that time. Prior to joining Amylin Mr. Bradbury spent ten years at SmithKline Beecham Pharmaceuticals where he held a number of sales and marketing positions. He is a member of the board of directors of Illumina Inc. and Novacea Inc. He also serves as a board member for PhRMA BIOCOM the Keck Graduate Institute’s Board of Trustees and the San Diego Regional Economic Development Corporation. Mr. Bradbury is a member of the Royal Pharmaceutical Society of Great Britain and serves on the UCSD Rady School of Management’s Advisory Council. He received a Bachelor of Pharmacy from Nottingham University and a Diploma in Management Studies from Harrow and Ealing Colleges of Higher Education. | 